🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT07725965
Active, not recruiting Observational

Artificial Intelligence(AI) in the Emergency Department (ED) in Cologne

NCT07725965 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2026-07-01
Last updated
2026-07-28

Condition(s) studied

Emergency CareClinical Decision SupportTriage

Study summary

This retrospective, non-interventional study evaluates the prognostic performance of open-weight Large Language Models (LLMs) in the setting of a German academic emergency department. Using a full census of all consecutive emergency department cases at University Hospital Cologne between 01 January 2023 and 31 December 2025 (approximately 100,000 cases), the study assesses whether LLMs can make reliable prognostic predictions (e.g., hospital admission, imaging, diagnosis, placement) based on the initial history, vital signs, and triage category. In addition, it quantifies how strongly automated anonymization and perturbation procedures affect the models' diagnostic accuracy. This is an Investigator-Initiated Trial (IIT) with no intervention on patients.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All consecutive treatment cases at the Central Emergency Department of University Hospital Cologne during the period 01 January 2023 - 31 December 2025 (full census, consecutive inclusion). Exclusion Criteria: * Documented objection to the scientific use of the data pursuant to Art. 21 General data protection Regulation (GDPR). * Cases lacking the minimum data required for analysis (triage/history and documented outcome).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Internal Medicine II, University Hospital Cologne Cologne Germany

More University of Cologne trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07725965 on ClinicalTrials.gov ↗ ← All trials in Germany